National Health Investors Overview
National Health Investors (NHI) has a ROE of 9036.41%, above the Finance sector average of 16.73%.
Get informed when a big investor buys or sells
+ Follow9036.41%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
National Health Investors (NHI) currently reports a ROE of 9036.41%. That is above the Finance sector average of 16.73%. Use the charts on this page to explore National Health Investors's ROE history and peer comparisons.
National Health Investors's ROE of 9036.41% is higher than the Finance sector average of 16.73%. That is roughly 53910.9% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but National Health Investors's current 9036.41% should be judged against Finance norms (sector average: 16.73%) and against NHI's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 9036.41%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Finance average is 16.73%. From there, open related valuation or income-statement pages for National Health Investors, and consider following NHI for alerts when major investors trade the stock.
National Health Investors is classified in the Finance sector. On ROE, it currently shows 9036.41% versus a sector average near 16.73%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Finance are usually more informative than comparing NHI with unrelated industries.
